Efficacy of daratumumab combination regimen in patients with multiple myeloma : A combined analysis of phase III randomized controlled trials

Htut, Thura W.Thein, Kyaw Z.Lawrie, AlastairTighe, JanePreston, Gavin2020-08-312020-08-312020-07Htut, T W, Thein, K Z, Lawrie, A, Tighe, J & Preston, G 2020, 'Efficacy of daratumumab combination regimen in patients with multiple myeloma : A combined analysis of phase III randomized controlled trials', eJHaem, vol. 1, no. 1, pp. 262-266. https://doi.org/10.1002/jha2.462688-6146RIS: urn:3340C2966E1E1C7F4B003185997A348Chttps://hdl.handle.net/2164/15035Open Access via the Jis Wiley Agreement5878285engdaratumumabmeta-analysismultiple myelomaphase III randomized controlled trialsR MedicineREfficacy of daratumumab combination regimen in patients with multiple myeloma : A combined analysis of phase III randomized controlled trialsJournal article10.1002/jha2.4611